Werewolf Therapeutics Inc... (HOWL)
1.38
0.03 (2.22%)
At close: Jan 15, 2025, 3:48 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -37.37M | -53.81M | -49.98M | -15.04M | -10.25M |
| Depreciation & Amortization | 1.76M | 1.10M | 216.00K | 150.00K | 25.00K |
| Stock-Based Compensation | 8.01M | 7.40M | 4.09M | 632.00K | 559.00K |
| Other Working Capital | -7.14M | 3.42M | 1.27M | 1.92M | -827.00K |
| Other Non-Cash Items | 878.00K | 2.17M | 519.00K | 627.00K | 950.00K |
| Deferred Income Tax | n/a | n/a | n/a | -7.30M | -117.00K |
| Change in Working Capital | -5.89M | 2.54M | 2.28M | 2.31M | -711.00K |
| Operating Cash Flow | -32.61M | -40.60M | -42.88M | -18.62M | -9.54M |
| Capital Expenditures | -769.00K | -3.61M | -498.00K | -560.00K | -266.00K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -769.00K | -3.61M | -498.00K | -560.00K | -266.00K |
| Debt Repayment | 40.00M | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 100.00K | 166.00K | -2.17M | 94.02M | 21.91M |
| Financial Cash Flow | 58.43M | 15.91M | 109.43M | 93.86M | 21.91M |
| Net Cash Flow | 25.05M | -28.30M | 66.05M | 74.67M | 12.10M |
| Free Cash Flow | -33.38M | -44.21M | -43.37M | -19.18M | -9.81M |